National Cervical Screening Program renewal
Medical Services Advisory Committee
Record ID 32015000440
English
Authors' recommendations:
After considering the strength of the available evidence in relation to the safety, clinical effectiveness and cost-effectiveness of a cervical screening pathway for the National Cervical Screening Program, MSAC supports public funding for:
• five-yearly cervical screening using a primary human papillomavirus (HPV) test with partial HPV genotyping and reflex liquid-based cytology (LBC) triage, for HPV vaccinated and unvaccinated women 25 to 69 years of age, with exit testing of women up to 74 years of age;
• self-collection of an HPV sample, for an under-screened or never-screened woman, which has been facilitated by a medical or nurse practitioner (or on behalf of a medical practitioner) who also offers mainstream cervical screening;
• invitations and reminders to be sent to women 25 to 69 years of age, and exit communications to be sent to women 70 to 74 years of age, to ensure the effectiveness of the program; and
• the de-listing of the existing cervical screening test MBS items over a 6 to 12 month transition period.
MSAC further advised that, if the HPV test cost in this program exceeds the modelled fee by too much, then this support would no longer apply, because the test would not be acceptably cost-effective.
MSAC also advised that the liquid-based cytology (LBC) test pricing may need to be revised with consideration to its future use as a reflex test and the change in its prevalence of use from a high volume test to a lower volume test with higher diagnostic value and therefore being subjected to greater quality assurance.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.msac.gov.au/internet/msac/publishing.nsf/Content/1276-public
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Cervical Intraepithelial Neoplasia
- Uterine Cervical Neoplasms
- Mass Screening
- Papanicolaou Test
- Papillomavirus Infections
Contact
Organisation Name:
Medical Services Advisory Committee
Contact Address:
MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
msac.secretariat@health.gov.au
Contact Email:
msac.secretariat@health.gov.au
Copyright:
Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.